Osteoporosis Posters and Abstracts from Atlanta

This activity is supported by an independent education grant from Merck Sharp & Dohme Corp and Radius Health, Inc.

Scroll to the Bottom of this Information to Begin this Course

Release date: November 23, 2016

Valid through: November 22, 2017

Specialty: Endocrinology, Rheumatology, Primary Care, Hospitalist

Estimated Time to Complete Activity: 1.0 hour

Target Audience

The target learning audience is endocrinologists, rheumatologists, primary care physicians, orthopedic surgeons, hospitalists, radiologists, and other health care providers who manage patients with osteoporosis.

Program Overview

Listen to Steven T. Harris, MD, Clinical Professor of Medicine, University of California, San Francisco, provide his perspectives on key posters presented on the management of patients with osteoporosis.

Proceed at your own pace and in any order. Each poster perspective is about 6 minutes.

Compare your knowledge against your peers.

Content Areas

  • Safety and efficacy of the anabolic agents abaloparatide-SC and romosozumab
  • Safety and efficacy of the cathepsin K inhibitor odanacatib
  • Long-term effect of bisphosphonates on mortality risk

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Summarize the latest research developments in the treatment of osteoporosis
  • Incorporate evidence-based research into clinical practice

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit

All other healthcare professionals completing this course will be issued a statement of participation.


Steven T. Harris, MD

Clinical Professor of Medicine
University of California, San Francisco
San Francisco, California

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designations

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:

Steven T. Harris, MD
  • Consultant: Gilead Sciences, Lilly, Merck, Radius Health
  • Speakers Bureau: Gilead Sciences, Lilly, Shire

Additional content planners

The following have no significant relationship to disclose:

Cheryl Lambing, MD (peer reviewer)
Greg Scott, PharmD, RPh (medical writer)

Annenberg Center for Health Sciences
John Bayliss, VP, Business Development, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.


Instructions for Participation and Credit

There are no fees for participating and receiving credit for this activity. During the accredited period, participants must read the learning objectives and faculty disclosures; study the educational activity; and complete the post-test and the evaluation form. If you pass the post-test and complete the evaluation, your certificate will be available immediately for download in PDF format.



Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Microsoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.

Disclosure of Unlabeled Use

The faculty for this activity has disclosed that there will be no discussion about the use of products for non-FDA approved applications.


It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.